supplementOTC supplementGastrointestinal upset was the most commonly reported adverse effect in the pooled trials
Bacopa MonnieriBenefits, Dosage & Interactions
Also known as: Brahmi
Bacopa monnieri is an ayurvedic herb whose active bacoside compounds have been tested in randomized trials for memory and learning. Meta-analyses find modest improvements in delayed word recall and information-processing speed, but only after roughly 8–12 weeks of daily use — it is not acute.
How much Bacopa Monnieri do people take?
Trials pooled in the meta-analysis used roughly 300-450 mg/day of standardized Bacopa extract. Route reported: Oral capsules or tablets of standardized whole-plant extract. Frequency reported: Once or twice daily with food in the trials. These are amounts documented in the cited studies and labels for Bacopa Monnieri — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
See the full reported protocol and its sourcesResearched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Strong — 1 human randomized trial published.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial published.
Quick answer
Bacopa monnieri is an ayurvedic herb whose active bacoside compounds have been tested in randomized trials for memory and learning. Meta-analyses find modest improvements in delayed word recall and information-processing speed, but only after roughly 8–12 weeks of daily use — it is not acute. Gastrointestinal upset is the most common complaint, and taking it with food reduces that.
- Class
- Ayurvedic nootropic herb (bacoside saponins)
- Amounts studied
- Typically 300 mg/day of extract standardized to ~50% bacosides
- Time to effect
- 8–12 weeks of continuous use in most trials
- Best measured effect
- Delayed recall; smaller effects on processing speed
- Common side effects
- Nausea, cramping, loose stools, dry mouth
- Best taken
- With food; often split across the day
Compiled by DoseRoutine from public sources including NIH/MedlinePlus, the FDA label, Mayo Clinic and PubChem. Educational information, not medical advice.
Plasma half-life
Not applicable
Typical timing
in the morning
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
Reported for Bacopa Monnieri in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Bacopa Monnieri entry is written from. Each number matches an inline marker above.
- [1]Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extractKongkeaw C, Dilokthornsakul P, Thanarangsarit P, et al. · Journal of Ethnopharmacology · 2014 · Peer-reviewed · PMID 24252493
- [2]Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trialCalabrese C, Gregory WL, Leo M, et al. · Journal of Alternative and Complementary Medicine · 2008 · Peer-reviewed · PMID 18611150
- [3]Plant-derived nootropics and human cognition: A systematic reviewLorca C, Mulet M, Arevalo-Caro C, et al. · Critical Reviews in Food Science and Nutrition · 2023 · Peer-reviewed · PMID 34978226
What is Bacopa Monnieri studied for?
What is Bacopa Monnieri?
Bacopa Monnieri, also known by its traditional name Brahmi, is a perennial, creeping herb native to wetlands in India, Australia, Europe, Asia, and Africa. It has been used for centuries in Ayurvedic medicine for a variety of purposes, particularly for memory improvement and cognitive enhancement. The plant is typically consumed orally as an extract, powder, or part of herbal formulations. Its primary active compounds are a group of triterpenoid saponins known as bacosides. These bacosides are believed to be responsible for most of its pharmacological effects. Bacopa Monnieri is often categorized as an adaptogen, implying it may help the body adapt to stress and support overall well-being. Its use has gained attention in modern research for its potential role in cognitive function, stress reduction, and neuroprotection.
What does the research say about Bacopa Monnieri?
Tap a section to expand.
The exact mechanisms by which Bacopa Monnieri exerts its effects are complex and multifaceted, primarily attributed to its active bacosides. Research suggests several pathways (Examine.com, PubChem). Bacosides are thought to enhance synaptic communication and nerve impulse transmission by modulating neurotransmitter systems. Specifically, they may influence acetylcholine, a key neurotransmitter involved in memory and learning, by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine. This leads to increased acetylcholine availability in the brain.
Additionally, Bacopa Monnieri appears to have antioxidant properties. It can scavenge reactive oxygen species and enhance the activity of antioxidant enzymes like superoxide dismutase (SOD) and catalase, thereby protecting neurons from oxidative damage. Oxidative stress is implicated in various neurodegenerative disorders and cognitive decline, so its antioxidant action may contribute to its neuroprotective effects.
Furthermore, Bacopa Monnieri may modulate brain-derived neurotrophic factor (BDNF) levels, which are crucial for neuronal growth, survival, and plasticity. It has also been observed to reduce inflammation in the brain, a factor that can impair cognitive function. Some studies suggest it may influence serotonin and dopamine systems, contributing to its potential anxiolytic and antidepressant-like effects. The adaptogenic properties are believed to be linked to its ability to modulate the body's stress response systems, including the hypothalamic-pituitary-adrenal (HPA) axis.
Bacopa Monnieri has been studied for several potential health benefits, particularly those related to cognitive function and stress management (Cochrane, Examine.com).
* **Cognitive Enhancement:** Numerous studies have investigated Bacopa's effects on various aspects of cognition. It is commonly studied for its potential to improve memory, particularly delayed recall and information retention. Some research suggests it may enhance learning rate and processing speed.
* **Stress and Anxiety Reduction:** As an adaptogen, Bacopa Monnieri may help reduce symptoms of stress and anxiety. Studies have reported a decrease in perceived stress and improvements in mood, potentially by modulating stress hormones and neurotransmitter systems.
* **Neuroprotection:** The antioxidant properties of bacosides may help protect brain cells from damage caused by free radicals. This neuroprotective effect is of interest in the context of age-related cognitive decline and neurodegenerative conditions.
* **Attention and Focus:** Some evidence indicates that Bacopa Monnieri might improve attention and reduce impulsivity, particularly in populations where these are areas of concern.
It is important to note that while research is promising, the extent and consistency of these benefits can vary, and more large-scale, long-term studies are often needed to confirm initial findings.
Bacopa Monnieri has been the subject of numerous research studies, primarily focusing on its cognitive and anxiolytic effects (Cochrane, NIH ODS, Examine.com). A significant body of evidence, including randomized controlled trials, suggests that Bacopa Monnieri can improve certain aspects of memory and cognitive function in healthy adults and in elderly individuals. For instance, several meta-analyses and systematic reviews have concluded that Bacopa Monnieri may enhance free recall and improve composite memory scores.
Regarding its effects on stress and anxiety, studies have shown reductions in subjective anxiety levels and mood improvements. Some trials have indicated its potential to mitigate stress-induced cognitive impairment. The strength of this evidence varies, with some studies showing more robust effects than others, and methodological differences contributing to variability in findings. Overall, the scientific community recognizes Bacopa Monnieri as a promising natural compound for cognitive support and stress management, with a generally favorable safety profile. However, ongoing research continues to refine our understanding of its efficacy and optimal application in diverse populations.
While generally considered safe for most people, Bacopa Monnieri can cause some side effects, primarily gastrointestinal in nature (Mayo Clinic, Examine.com). Common side effects include:
* Nausea
* Stomach cramps
* Diarrhea
* Dry mouth
* Fatigue
These side effects are typically mild and often resolve with continued use or by taking the supplement with food. Some individuals may experience an increase in bowel movements. Less commonly, very high doses might lead to more pronounced gastrointestinal discomfort. If any side effects are persistent or severe, it is advisable to discontinue use and consult a healthcare professional. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Individuals with certain pre-existing conditions or those undergoing specific medical treatments should exercise caution when considering Bacopa Monnieri (NIH ODS, Mayo Clinic). Due to its potential influence on neurotransmitter systems, individuals with thyroid disorders should consult a clinician, as Bacopa Monnieri might affect thyroid hormone levels. Similarly, those with slow heart rates (bradycardia) or conditions that might be exacerbated by increased cholinergic activity should use caution. There is also a theoretical concern for individuals with lung conditions like asthma or emphysema that might worsen with increased cholinergic tone, as well as those with urinary obstruction or ulcers, as it may increase secretions. Pregnant and breastfeeding women are generally advised to avoid Bacopa Monnieri due to insufficient safety data. Children and adolescents should only use it under medical supervision. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Absolute contraindications for Bacopa Monnieri are not extensively documented in medical literature, but certain conditions warrant strict avoidance or very cautious use under medical supervision (NIH ODS, DrugBank). Individuals with known hypersensitivity or allergy to Bacopa Monnieri or its components should avoid it. Due to its potential to affect thyroid hormones, individuals with existing thyroid conditions, especially hyperthyroidism, should exercise extreme caution or avoid use unless specifically advised by a healthcare professional. People with severe bradycardia or other significant heart rhythm abnormalities should also avoid it due to its potential to affect heart rate. Individuals with gastrointestinal obstructions or severe peptic ulcers should reconsider its use due to potential effects on gut motility and secretions. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Bacopa Monnieri may interact with certain medications and other supplements (DrugBank, MedlinePlus). Key interactions to be aware of include:
* **Thyroid Hormones:** Bacopa Monnieri may increase thyroid hormone levels, potentially interacting with thyroid medication and necessitating dose adjustments. Individuals on levothyroxine or similar medications should be cautious.
* **Cholinergics and Anticholinergics:** As Bacopa may increase acetylcholine, it could theoretically enhance the effects of cholinergic drugs (e.g., donepezil for Alzheimer's) or counteract the effects of anticholinergic drugs (e.g., atropine, scopolamine).
* **Sedatives:** Bacopa Monnieri may have mild sedative effects in some individuals. Combining it with other sedatives (e.g., benzodiazepines, alcohol, hypnotics) could lead to excessive drowsiness.
* **Other Herbs/Supplements:** Caution is advised when combining Bacopa with other herbs known to affect cognitive function, mood, or thyroid activity, as additive or synergistic effects are possible. Examples include ashwagandha, piracetam, or ginkgo biloba.
Always discuss all medications and supplements with a healthcare provider before adding Bacopa Monnieri. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Bacopa Monnieri is typically recommended to be taken in the morning. This timing is often suggested to align with its potential cognitive-enhancing effects throughout the day. It is generally advised to take Bacopa Monnieri with food. Taking it with a meal can help minimize potential gastrointestinal side effects such as nausea or stomach upset, which are some of the more commonly reported adverse effects. The fatty acids present in food can also aid in the absorption of bacosides, which are fat-soluble compounds, potentially enhancing its bioavailability and efficacy. Consistent daily intake is generally recommended for optimal benefits, as its effects are often gradual and accrue over several weeks or months rather than being acute.
Put it into practice
Reading about Bacopa Monnieri is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with Bacopa Monnieri?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any glp1 + supplement | Note | Category ruleConfidence: theoretical | GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pending | Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider. |
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
Frequently asked questions about Bacopa Monnieri
The cognitive benefits of Bacopa Monnieri are generally not immediate. Most studies suggest that sustained daily intake over several weeks to months (e.g., 8-12 weeks) is required to experience noticeable improvements in memory and other cognitive functions. Its effects accumulate over time.
Preliminary research has explored Bacopa Monnieri's potential for improving attention, impulsivity, and restlessness, particularly in children and adolescents with ADHD. While some studies show promising results, more robust clinical trials are needed to definitively establish its efficacy and role in ADHD management. It should not replace conventional treatments without medical guidance.
Bacopa Monnieri has a history of long-term use in Ayurvedic medicine, and modern studies have generally found it to be well-tolerated for periods of several months. However, long-term safety data in large populations are still less extensive than for pharmaceutical drugs. Regular medical check-ups are always advisable with any long-term supplement use.
While some individuals report mild fatigue or sedation as a side effect, Bacopa Monnieri is not typically considered a strong sedative. Most people do not experience significant drowsiness, especially at commonly studied dosages. If you experience unusual fatigue, it may be a personal reaction or indicate an interaction with other substances.
Bacopa Monnieri is a supplement, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Bacopa Monnieri is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Bacopa Monnieri with no sign-up.
Bacopa Monnieri is typically taken in the morning. Published protocols usually have it taken with food. Ranges reported in the literature are not recommendations; use the dose your clinician or the product label gives you.
Combining a supplement like Bacopa Monnieri with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Each peptide class carries its own profile against Bacopa Monnieri: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Bacopa Monnieri varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Bacopa Monnieri depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Bacopa Monnieri the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Trials that found cognitive effects dosed daily for 8–12 weeks; studies of single doses generally find nothing. That slow onset is consistent with the proposed mechanisms — dendritic branching and antioxidant effects in the hippocampus — rather than acute neurotransmitter stimulation, so expecting a same-day effect misreads the evidence. This is educational information, not medical advice.
Digestive complaints dominate: nausea, abdominal cramping, increased stool frequency and dry mouth, largely dose-related and reduced by taking it with a meal. It has cholinergic activity, so caution is advised alongside cholinergic drugs, and it may add to the sedating effect of other calming agents. This is educational information, not medical advice.
The common protocol is 300 mg a day of an extract standardized to about 50 percent bacosides, or roughly 750–1,500 mg a day of a less concentrated whole-herb preparation. Comparing products by total milligrams is misleading unless the bacoside percentage is stated. This is educational information, not medical advice.
Trials pooled in the meta-analysis used roughly 300-450 mg/day of standardized Bacopa extract. Route reported: Oral capsules or tablets of standardized whole-plant extract. Frequency reported: Once or twice daily with food in the trials. These are amounts documented in the cited studies and labels for Bacopa Monnieri — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.
Which studies looked at Bacopa Monnieri?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract(opens PubMed in a new tab)J Ethnopharmacol · 2014 · PMID 24252493 · https://pubmed.ncbi.nlm.nih.gov/24252493/
- 2.Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial(opens PubMed in a new tab)J Altern Complement Med · 2008 · PMID 18611150 · https://pubmed.ncbi.nlm.nih.gov/18611150/
Verify at
Publisher search links for Bacopa Monnieri. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Bacopa Monnieri?
Plain-text summary, safe to quote verbatim:
Bacopa monnieri is an ayurvedic herb whose active bacoside compounds have been tested in randomized trials for memory and learning. Meta-analyses find modest improvements in delayed word recall and information-processing speed, but only after roughly 8-12 weeks of daily use - it is not acute.
Source: DoseRoutine — https://doseroutine.com/library/bacopa-monnieri
Bacopa Monnieri cheat sheet
DoseRoutine cheat sheet · Supplement
Bacopa Monnieri
Bacopa monnieri is an ayurvedic herb whose active bacoside compounds have been tested in randomized trials for memory and learning. Meta-analyses find modest improvements in delayed word recall and information-processing speed, but only after roughly 8–12 weeks of daily use — it is not acute.
Evidence
Strong
1 human randomized trial published.
Studied range
Trials pooled in the meta-analysis used roughly 300-450 mg/day of standardized Bacopa extract
Route
Oral capsules or tablets of standardized whole-plant extract
Frequency studied
Once or twice daily with food in the trials
Half-life
Bacoside pharmacokinetics in humans are poorly characterized
Timing
in the morning
With food
with food
Storage
Cool, dry, sealed
OTC supplementGastrointestinal upset was the most commonly reported adverse effect in the pooled trialsBrain
Key references
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract (2014)
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial (2008)
- Plant-derived nootropics and human cognition: A systematic review (2023)
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/bacopa-monnieri
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Bacopa Monnieri — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/bacopa-monnieri
What compounds are similar to Bacopa Monnieri?
Others in the supplement category or studied for the same goals.
Which goals is Bacopa Monnieri used for?
Other compounds studied for the same benefits as Bacopa Monnieri.
Continue exploring
See every compound DoseRoutine catalogs for these goals.